Focus: BlueWind Medical is an Israeli neurostimulation implant company founded in 2010, publicly traded and focused on neuromodulation treatments for neurological and cardiovascular conditions. The company specializes in implantable devices addressing unmet needs in bladder dysfunction, neuropathic pain, and other neurological disorders.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
No open roles listed right now. Follow BlueWind Medical to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Flagship tibial nerve stimulation platform addressing large OAB market with minimally invasive approach.
Help build intelligence for BlueWind Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from BlueWind Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Addresses chronic pain indication with significant unmet need and potential for broad patient reach.
Represents company's expansion into cardiovascular neuromodulation with potential for significant market opportunity.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo